SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-116029
Filing Date
2024-10-21
Accepted
2024-10-21 18:23:22
Documents
2
Period of Report
2024-10-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 14428
2 EX-24 aura-ex24.htm EX-24 14672
  Complete submission text file 0000950170-24-116029.txt   30519
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VERASTEM, INC. 117 KENDRICK STREET, SUITE 500 NEEDHAM MA 02494
Business Address
Feder Julie B (Reporting) CIK: 0001710237 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 241384342